Treatment of Polymicrobial Osteomyelitis with Ceftolozane-Tazobactam: Case Report and Sensitivity Testing of Isolates

Treatment of Polymicrobial Osteomyelitis with Ceftolozane-Tazobactam: Case Report and Sensitivity Testing of Isolates

Stenotrophomonas maltophilia is an inherently multidrug resistant (MDR) opportunistic pathogen with many mechanisms of resistance. SENTRY studies reveal decreasing sensitivities of S. maltophilia to trimethoprim-sulfamethoxazole and fluoroquinolones. Ceftolozane-tazobactam (Zerbaxa, Merck & Co.,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jeffrey C. Jolliff, Jackie Ho, Jeremiah Joson, Arash Heidari, Royce Johnson
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Case Reports in Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/2016/1628932
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mechanisms of ceftolozane/tazobactam resistance in Pseudomonas aeruginosa isolates from South Korea
by: Yu Mi Wi, et al.
Published: (2024-12-01)

Use of Ceftolozane/Tazobactam in a Case of Septic Shock by Puerperal Sepsis
by: Mario Pezzi, et al.
Published: (2019-01-01)

Ceftazidime-Induced Overexpression of MexJK-OprM Confers Resistance to Ceftolozane/Tazobactam in an Isolate of Pseudomonas aeruginosa
by: Sato T, et al.
Published: (2025-08-01)

Assessment of in vitro antimicrobial activities of ceftolozane/tazobactam and ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa clinical isolates
by: Dalia Salem, et al.
Published: (2025-04-01)

In vitro activity of ceftolozane/tazobactam against ESBL-producing enterobacterales in China: SMART 2016–2019
by: Wei Yu, et al.
Published: (2025-05-01)

Activity of ceftolozane/tazobactam against commonly encountered antimicrobial resistant Gram-negative bacteria in Lebanon
by: George F Araj, et al.
Published: (2020-06-01)

Use of Ceftolozane-Tazobactam in Patient with Severe Medium Chronic Purulent Otitis by XDR Pseudomonas aeruginosa
by: L. M. Saraca, et al.
Published: (2019-01-01)

Ceftolozane/tazobactam use and emergence of resistance: a 4-year analysis of antimicrobial susceptibility in Pseudomonas aeruginosa isolates in a tertiary hospital
by: Alessandra Imeneo, et al.
Published: (2025-04-01)

Collateral susceptibility-guided alternation of ceftolozane/tazobactam with imipenem prevents resistance development in XDR Pseudomonas aeruginosa biofilms
by: María Fernández-Billón, et al.
Published: (2024-12-01)

Unveiling results and insights from multinational, multicenter Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA)
by: Alex Soriano, et al.
Published: (2025-03-01)

Activity of ceftolozane-tazobactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
by: Brian D Johnston, et al.
Published: (2018-01-01)

CEFTOLOZANE/TAZOBACTAM AND CEFTAZIDIME/AVIBACTAM: TWO NOVEL в-LACTAM / β-LACTAMASE INHIBITOR COMBINATION AGENTS FOR THE TREATMENT OF RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS
by: J. L. Liscio, et al.
Published: (2020-05-01)

Reliability of various antimicrobial susceptibility testing methods for piperacillin/tazobactam in challenging Escherichia coli isolates
by: Faruk Demirocak, et al.
Published: (2025-03-01)

Tazobactam selects for multidrug resistance
by: Emma R. Holden, et al.
Published: (2025-05-01)

The role of piperacillin/tazobactam in the treatment of Hidradenitis suppurativa
by: Aviv Barzilai, et al.
Published: (2024-12-01)

First Isolation of C. auris in a Patient with a Polymicrobial Wound Infection in Jamaica
by: Dr Niel Mcknight, et al.
Published: (2025-03-01)

Piperacillin-tazobactam: prospects for use in real-world practice
by: Yu. M. Gomon
Published: (2023-10-01)

Piperacillin/Tazobactam as Cause of Acute Generalized Exanthematous Pustulosis
by: Aikaterini Kyriakou, et al.
Published: (2019-01-01)

Isolated cryptococcal osteomyelitis in an immunocompetent patient
by: Irfan Qadir, et al.
Published: (2011-07-01)

Pharmacodynamics of interspecies interactions in polymicrobial infections
by: C. Herzberg, et al.
Published: (2025-01-01)

EP-066 - MIELOTOXICIDADE PELO USO DE PIPERACILINA-TAZOBACTAM
by: Antonio Sérgio Mathias, et al.
Published: (2024-10-01)

A case of isolated nasal bone osteomyelitis
by: Gurcharan Singh, et al.
Published: (2014-06-01)

Melittin Inhibition and Eradication Activity for Resistant Polymicrobial Biofilm Isolated from a Dairy Industry after Disinfection
by: Emilia Galdiero, et al.
Published: (2019-01-01)

Polymicrobial Infection of the Cornea Due to Contact Lens Wear
by: Selçuk Sızmaz, et al.
Published: (2016-04-01)

A Case of Polymicrobial, Gram-Negative Pulmonic Valve Endocarditis
by: Tatiana Bekker, et al.
Published: (2019-01-01)

The importance of understanding pelvic inflammatory disease as a polymicrobial infection
by: Kenyon Chris
Published: (2024-12-01)

Impact of thermoneutral acclimation on a murine model of polymicrobial peritonitis
by: Goldia Chan, et al.
Published: (2025-01-01)

Polymicrobial detection and salivary metabolomics of children with early childhood caries
by: Ting Pan, et al.
Published: (2025-05-01)

A Case of Polymicrobial Bacteremia in a Patient Undergoing Chemotherapy
by: Kyoko Arahata, et al.
Published: (2018-01-01)

Ability of Linezolid to Combat <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i> Isolated from Polymicrobial Wound Infections
by: Samar A. Ahmed, et al.
Published: (2025-06-01)

Comparison of the effect of carbapenem and piperacillin-tazobactam on the development of fecal colonization with carbapenem resistant Enterobacterales
by: Tuğba Pamukçu, et al.
Published: (2024-12-01)

Compliance of extended infusion of piperacillin/tazobactam with the desired pharmacokinetic/pharmacodynamic index in septic patients
by: Tomić Nataša, et al.
Published: (2025-01-01)

COMPARISON OF ANTIMICROBIAL SENSITIVITY TO OLDER AND NEWER QUINOLONES VERSUS PIPERACILLIN-TAZOBACTAM, CEFEPIME AND MEROPENEM IN FEBRILE PATIENTS WITH CANCER IN TWO REFERRAL PEDIATRIC CENTERS IN TEHRAN, IRAN
by: Ali Nateghian, et al.
Published: (2014-06-01)

Characteristics of Atypical Forms of Staphylococci (SCVs) Isolated from Patients with Osteomyelitis
by: L. N. Churkina, et al.
Published: (2020-05-01)

Ertapenem Articulating Spacer for the Treatment of Polymicrobial Total Knee Arthroplasty Infection
by: Dragan Radoicic, et al.
Published: (2016-01-01)

The Role of the Vagus Nerve: Modulation of the Inflammatory Reaction in Murine Polymicrobial Sepsis
by: Wolfram Kessler, et al.
Published: (2012-01-01)

HNF4α contributes to hepatic CAR dysfunction in polymicrobial sepsis
by: Céline Van Dender, et al.
Published: (2025-08-01)

Polymicrobial urine cultures: reconciling contamination with the urobiome while recognizing the pathogens
by: Robert B. Moreland, et al.
Published: (2025-05-01)

Analysis of local and systemic inflammatory responses induced by polymicrobial peritonitis in mice
by: Tânia Silvia Fröde, et al.
Published: (2001-01-01)

Polymicrobial interactions of Helicobacter pylori and its role in the process of oral diseases
by: Yufei Fan, et al.
Published: (2025-12-01)